Strategies of stabilization of zein nanoparticles containing doxorubicin hydrochloride
Authors:
- 5 June 2023
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 243, 125222
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 48 references indexed in Scilit:
- Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic responseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- PEG — A versatile conjugating ligand for drugs and drug delivery systemsJournal of Controlled Release, 2014
- Zein in controlled drug delivery and tissue engineeringJournal of Controlled Release, 2014
- An overview of doxorubicin formulations in cancer therapyJournal of Cancer Research and Therapeutics, 2014
- Nanomedicine therapeutic approaches to overcome cancer drug resistanceAdvanced Drug Delivery Reviews, 2013
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manageJournal of Controlled Release, 2013
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJournal of Pharmacy and Pharmacology, 2013
- State of the art in PEGylation: The great versatility achieved after forty years of researchJournal of Controlled Release, 2012
- Doxil® — The first FDA-approved nano-drug: Lessons learnedJournal of Controlled Release, 2012
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology, 2004